Skip to main content

Nonprofit · EIN 04-2763124

DRUG RESEARCH GROUP INC

Tax-exempt · LEXINGTON, MA 02421

Financials

$576K$997K2022$570K$815K2023$1.2M$787K2024
Revenue Expenses · by fiscal year end
Financials of DRUG RESEARCH GROUP INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$1,189,041$786,795$402,246$1,046,880$21,744$1,025,136
June 30, 2024990$569,545$815,349-$245,804$607,287$18,748$588,539
June 30, 2023990$576,423$997,184-$420,761$879,306$33,922$845,384
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$483,680
Program service revenue
$0
Investment income
$705,361
Net gain from sales of assets
$699,622
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$207,090
Other salaries and wages
$218,045
Salaries, compensation and benefits (total)
$535,306
Professional fundraising fees
$0
Accounting fees
$9,250
Occupancy
$8,000
Travel
$10,286
Depreciation
$12,650
Program services (functional)
$725,178
Management and general (functional)
$61,617

Balance sheet and other

Total assets, start of year
$607,287
Total assets, end of year
$1,046,880
Total liabilities, end of year
$21,744
Net assets, end of year
$1,025,136
Land, buildings and equipment
$29,752
Publicly traded securities
$471,858
Net assets without donor restrictions
$1,025,136
Gross receipts
$1,580,745
Employees
6
Volunteers
0
Year formed
1981
State of legal domicile
MA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensation
SUSAN JICKPRESIDENT
Officer
20$85,810
MICHAEL J HORTONTREASURER/CLERK
Officer
40$73,104
KATRINA W HAGBERGDIRECTOR
Trustee or director
40$71,499
THEODORE COLTONDIRECTOR
Trustee or director
20$0
LAURA E DERBYDIRECTOR
Trustee or director
20$0
MARIANNE ULCICKAS YOODDIRECTOR
Trustee or director
20$0
KATHLEEN MCMAHON JICKDIRECTOR
Trustee or director
20$0
990 for the year ended June 30, 2024: 7 people
NameTitleHours / weekCompensation
KATRINA W HAGBERGDIRECTOR
Trustee or director
20$75,000
MICHAEL J HORTONTREASURER/CLERK
Officer
20$75,000
SUSAN JICKPRESIDENT
Officer
20$66,000
THEODORE COLTONDIRECTOR
Trustee or director
20$0
LAURA E DERBYDIRECTOR
Trustee or director
20$0
MARIANNE ULCICKAS YOODDIRECTOR
Trustee or director
20$0
KATHLEEN MCMAHON JICKDIRECTOR
Trustee or director
20$0
990 for the year ended June 30, 2023: 7 people
NameTitleHours / weekCompensation
SUSAN JICKPRESIDENT
Officer
20$95,207
KATRINA W HAGBERGDIRECTOR
Trustee or director
20$65,625
THEODORE COLTONDIRECTOR
Trustee or director
20$0
LAURA DERBYDIRECTOR
Trustee or director
20$0
MARIANNE ULCICKAS YOODDIRECTOR
Trustee or director
20$0
KATHLEEN MCMAHON JICKDIRECTOR
Trustee or director
20$0
MICHAEL J HORTONTREASURER/CLERK
Officer
20$0

Address and contacts

Address (IRS master file)
55 WALTHAM ST, LEXINGTON, MA 02421-5406
Principal officer (990 for 2024)
SUSAN JICK, 55 WALTHAM ST, LEXINGTON, MA 02421
Signed the 990
SUSAN JICK, PRESIDENT
Phone
(781) 862-6660
Return prepared by
TREEFUL DAMASO ANICETO INC

Mission

TO PERFORM RESEARCH TO PROVIDE QUANTITATIVE DATA ON THE FREQUENCY OF SIDE EFFECTS TO ALL MARKETED AND OVER THE COUNTER DRUGS.

990 for the year ended June 30, 2025

Program accomplishments

  • OVER THE COUNTER AND PRESCRIPTION DRUG RESEARCH-QUANTITATIVE DATA ON THE SIDE EFFECTS OF OVER THE COUNTER AND PRESCRIPTION DRUGS
    Expenses $725,178

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
04-2763124
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1983
Accounting year ends
June
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E66E)
Assets (IRS master file)
$1,046,880
Income (IRS master file)
$1,580,745

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$1,189,041$786,795$1,046,880XML
990June 2024$569,545$815,349$607,287XML
990June 2023$576,423$997,184$879,306XML
990June 2022$255,612$996,850$1,272,221IRS
990June 2021–––IRS
990June 2020–––IRS
990June 2019–––IRS
990June 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-2763124).

Questions about DRUG RESEARCH GROUP INC

What is the EIN of DRUG RESEARCH GROUP INC?
The employer identification number (EIN) of DRUG RESEARCH GROUP INC is 04-2763124.
Is DRUG RESEARCH GROUP INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1983.
Are donations to DRUG RESEARCH GROUP INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does DRUG RESEARCH GROUP INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of DRUG RESEARCH GROUP INC due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did DRUG RESEARCH GROUP INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of DRUG RESEARCH GROUP INC?
The 990 for the year ended June 30, 2025 names SUSAN JICK.
Who are the officers and directors of DRUG RESEARCH GROUP INC?
The 990 for the year ended June 30, 2025 lists 7 people; 3 received compensation from the organization, the highest $85,810 (SUSAN JICK, PRESIDENT).
How much revenue does DRUG RESEARCH GROUP INC have?
On its 990 for the year ended June 30, 2025 it reported revenue of $1,189,041, expenses of $786,795 and total assets of $1,046,880 at year end.

Other nonprofits in LEXINGTON

All nonprofits in LEXINGTON · Massachusetts · Health care